Canadian researchers found that patients with immune-mediated inflammatory diseases (IMIDs) don’t face a heightened risk of venous thromboembolism events after recovering from COVID-19 compared to those without IMIDs. However, certain comorbidities can influence this risk, emphasizing the importance of individualized patient care.
A harm-reduction approach to eating out
Several years ago, while on a road trip, I ordered the now-discontinued spaghetti and meatballs during a pitstop at Denny’s. When the plate came out,
August 23, 2024